INGENIA Therapeutics
Developer of a therapeutic antibody candidate designed for capillary diseases. The company specializes in discovering and developing antibody candidates for patient populations suffering from defectiv...
Valuation
$100M
Latest known
Share Price
N/A
Total Raised
$17M
Last Round
N/A